Ірландія - англійська - HPRA (Health Products Regulatory Authority)

teva b.v. - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

rowex ltd - darunavir - film-coated tablet - 75 milligram(s) - protease inhibitors; darunavir

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

rowex ltd - darunavir - film-coated tablet - 400 milligram(s) - protease inhibitors; darunavir

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

rowex ltd - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - darunavir - film-coated tablet - 800 milligram(s) - protease inhibitors; darunavir

Ізраїль - англійська - Ministry of Health

j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Ізраїль - англійська - Ministry of Health

j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Європейський Союз - англійська - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ritonavir - hiv infections - antivirals for systemic use, - ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv-1-infected patients (adults and children of two years of age and older).,

Європейський Союз - англійська - EMA (European Medicines Agency)

roche registration ltd. - nelfinavir - hiv infections - antivirals for systemic use - viracept is indicated in antiretroviral combination treatment of human-immunodeficiency-virus (hiv-1)-infected adults, adolescents and children of three years of age and older.in protease-inhibitor (pi)-experienced patients, the choice of nelfinavir should be based on individual viral resistance testing and treatment history.